Menlo Therapeutics Inc. announced the hiring of Ronald A. Krasnow as General Counsel and Chief Compliance Officer. In this role, Mr. Krasnow will be responsible for all legal needs of the company including intellectual property portfolio development and supporting the company’s commercial, clinical, regulatory, manufacturing and development functions to ensure compliance with all applicable laws, rules and regulations. Most recently, Mr. Krasnow served as General Counsel, Chief Strategy Officer and Secretary at Kinestral Technologies Inc., a company focused on bringing cutting edge technology to the home and commercial construction markets. Prior to Kinestral, Ron spent approximately ten years as General Counsel at Relypsa Inc., overseeing legal activities as the biotech company grew from a start-up, through its IPO, commercialization of its drug and its acquisition by Galenica.